Gene · 4926
Papers2,697
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,697
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| FERM domain-containing proteins are active components of the cell nucleus. | Life Sci Alliance | 2024 | 38296350 | PubTator, text mining | PubMed |
| Tumour tissue-derived small extracellular vesicles reflect molecular subtypes of bladder cancer. | J Extracell Vesicles | 2024 | 38293707 | PubTator, text mining | PubMed |
| Artificial intelligence assisted patient blood and urine droplet pattern analysis for non-invasive and accurate diagnosis of bladder cancer. | Sci Rep | 2024 | 38291121 | PubTator, text mining | PubMed |
| Recognition of rare antinuclear antibody patterns based on a novel attention-based enhancement framework. | Brief Bioinform | 2024 | 38279651 | PubTator, text mining | PubMed |
| The Importance of the Position of the Nucleus in Drosophila Oocyte Development. | Cells | 2024 | 38275826 | PubTator, text mining | PubMed |
| The LINC complex ensures accurate centrosome positioning during prophase. | Life Sci Alliance | 2024 | 38228373 | PubTator, text mining | PubMed |
| Natural killer cells drive 4-1BBL positive uveal melanoma towards EMT and metastatic disease. | J Exp Clin Cancer Res | 2024 | 38191418 | PubTator, text mining | PubMed |
| Identification and validation of prognostic signature genes of bladder cancer by integrating methylation and transcriptomic analysis. | Sci Rep | 2024 | 38172584 | PubTator, text mining | PubMed |
| Bladder cancer risk stratification with the Oncuria 10-plex bead-based urinalysis assay using three different Luminex xMAP instrumentation platforms. | J Transl Med | 2024 | 38167321 | PubTator, text mining | PubMed |
| NTRK-rearranged spindle cell sarcoma of the uterine cervix with a novel NUMA1::NTRK1 fusion. | Virchows Arch | 2024 | 38151535 | PubTator, text mining | PubMed |
| Cell polarity changes in cancer initiation and progression. | J Cell Biol | 2024 | 38091012 | PubTator, text mining | PubMed |
| SUMOylation is enriched in the nuclear matrix and required for chromosome segregation. | J Biol Chem | 2024 | 38072047 | PubTator, text mining | PubMed |
| Interplay between the plasma membrane and cell-cell adhesion maintains epithelial identity for correct polarised cell divisions. | J Cell Sci | 2024 | 37888135 | PubTator, text mining | PubMed |
| Comprehensive modular analyses of scar subtypes illuminate underlying molecular mechanisms and potential therapeutic targets. | Int Wound J | 2024 | 37697692 | PubTator, text mining | PubMed |
| Role of lipids in the control of autophagy and primary cilium signaling in neurons. | Neural Regen Res | 2024 | 37488876 | PubTator, text mining | PubMed |
| Complex patterns on HEp-2 indirect immunofluorescence assay in a large sample referred for anti-cell autoantibodies detection. | Front Immunol | 2023 | 38283335 | PubTator, text mining | PubMed |
Results Obtained from a Pivotal Validation Trial of a Microsatellite Analysis (MSA) Assay for Bladder Cancer Detection through a Statistical Approach Using a Four-Stage Pipeline of Modern Machine Learning Techniques. | Int J Mol Sci | 2023 | 38203643 | PubTator, text mining | PubMed |
| Qualification of the Microsatellite Instability Analysis (MSA) for Bladder Cancer Detection: The Technical Challenges of Concordance Analysis. | Int J Mol Sci | 2023 | 38203379 | PubTator, text mining | PubMed |
| Deciphering Urogenital Cancers through Proteomic Biomarkers: A Systematic Review and Meta-Analysis. | Cancers (Basel) | 2023 | 38201450 | PubTator, text mining | PubMed |
| Comparative study of electrochemical-based sensors and immunosensors in terms of advantageous features for detection of cancer biomarkers. | Turk J Chem | 2023 | 38173762 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4926/papers?page=6